These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26229689)

  • 21. Pratensein ameliorates β-amyloid-induced cognitive impairment in rats via reducing oxidative damage and restoring synapse and BDNF levels.
    Liang C; Tan S; Huang Q; Lin J; Lu Z; Lin X
    Neurosci Lett; 2015 Apr; 592():48-53. PubMed ID: 25748315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity.
    Stampanoni Bassi M; Iezzi E; Pavone L; Mandolesi G; Musella A; Gentile A; Gilio L; Centonze D; Buttari F
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroplasticity-Based Technologies and Interventions for Restoring Motor Functions in Multiple Sclerosis.
    Straudi S; Basaglia N
    Adv Exp Med Biol; 2017; 958():171-185. PubMed ID: 28093714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity.
    Buckle GJ
    J Neuroimaging; 2005; 15(4 Suppl):82S-93S. PubMed ID: 16385021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preserved brain adaptive properties in patients with benign multiple sclerosis.
    Rocca MA; Ceccarelli A; Rodegher M; Misci P; Riccitelli G; Falini A; Comi G; Filippi M
    Neurology; 2010 Jan; 74(2):142-9. PubMed ID: 20065249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disability in multiple sclerosis: when synaptic long-term potentiation fails.
    Weiss S; Mori F; Rossi S; Centonze D
    Neurosci Biobehav Rev; 2014 Jun; 43():88-99. PubMed ID: 24726576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain reorganization during attention and memory tasks in multiple sclerosis: insights from functional MRI studies.
    Mainero C; Pantano P; Caramia F; Pozzilli C
    J Neurol Sci; 2006 Jun; 245(1-2):93-8. PubMed ID: 16626753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Form follows function: BDNF and its involvement in sculpting the function and structure of synapses.
    Zagrebelsky M; Korte M
    Neuropharmacology; 2014 Jan; 76 Pt C():628-38. PubMed ID: 23752094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS.
    Prosperini L; Di Filippo M
    Mult Scler; 2019 Sep; 25(10):1348-1362. PubMed ID: 31469359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroplasticity and functional recovery in multiple sclerosis.
    Tomassini V; Matthews PM; Thompson AJ; Fuglø D; Geurts JJ; Johansen-Berg H; Jones DK; Rocca MA; Wise RG; Barkhof F; Palace J
    Nat Rev Neurol; 2012 Nov; 8(11):635-46. PubMed ID: 22986429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.
    Rossi S; Furlan R; De Chiara V; Motta C; Studer V; Mori F; Musella A; Bergami A; Muzio L; Bernardi G; Battistini L; Martino G; Centonze D
    Ann Neurol; 2012 Jan; 71(1):76-83. PubMed ID: 22275254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Functional magnetic resonance imaging in multiple sclerosis].
    Korsholm K; Mathiesen HK; Lund TE
    Ugeskr Laeger; 2007 Jun; 169(26):2518-20. PubMed ID: 17725897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis.
    Miller E
    Adv Exp Med Biol; 2012; 724():222-38. PubMed ID: 22411246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis.
    Giorgio A; Portaccio E; Stromillo ML; Marino S; Zipoli V; Battaglini M; Blandino A; Bartolozzi ML; Siracusa G; Amato MP; De Stefano N
    Mult Scler; 2010 Nov; 16(11):1326-34. PubMed ID: 20670979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
    Jean-Gilles L; Braitch M; Latif ML; Aram J; Fahey AJ; Edwards LJ; Robins RA; Tanasescu R; Tighe PJ; Gran B; Showe LC; Alexander SP; Chapman V; Kendall DA; Constantinescu CS
    Acta Physiol (Oxf); 2015 May; 214(1):63-74. PubMed ID: 25704169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal deprivation effects on brain plasticity and recognition memory in adolescent male and female rats.
    Marco EM; Valero M; de la Serna O; Aisa B; Borcel E; Ramirez MJ; Viveros MP
    Neuropharmacology; 2013 May; 68():223-31. PubMed ID: 22939999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity.
    Suri D; Vaidya VA
    Neuroscience; 2013 Jun; 239():196-213. PubMed ID: 22967840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
    Azoulay D; Urshansky N; Karni A
    J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGF but not BDNF overexpression protects hippocampal LTP from beta-amyloid-induced impairment.
    Ivanov AD; Tukhbatova GR; Salozhin SV; Markevich VA
    Neuroscience; 2015 Mar; 289():114-22. PubMed ID: 25595986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.